Codeletion of CDKN2B/CDKN2A genes is significantly related to the prognosis of NSCLC patients, whereby detecting codeletion of both genes might be used as a potential marker for NSCLC prognosis [83]. Here, CDKN2B is linked to non-small cell lung carcinoma.